1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study

BACKGROUND: STRIVE was conducted to assess the safety and efficacy of rezafungin (RZF), a novel echinocandin with pharmacokinetics allowing once weekly dosing and high, front-loaded plasma drug exposure, and to help determine dosing for a Phase 3 study. METHODS: Adults (≥18 years) with mycologically...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, George R, Vazquez, Jose, Soriano, Alex, Skoutelis, Athanasios, Ostrosky-Zeichner, Luis, Mena, Karen, Navalta, Laura, Sandison, Taylor, Pappas, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253007/
http://dx.doi.org/10.1093/ofid/ofy209.124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253007/
http://dx.doi.org/10.1093/ofid/ofy209.124

Ejemplares similares